MYD88 and neoplasm: Mechanistically, the ability of IL-33 to induce tumor-reactive IFN-γ+ CD107+ CD8+ T and NK cells was recently shown to be dependent on MyD88 signaling in a mouse model of Lewis lung carcinoma (25).